AGAM: Summary for AGA Medical Holdings, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 2:14pm EST - Canadian Markets close in 1 hour and 46 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

AGA Medical Holdings, Inc. (AGAM)

At 13:59 EST: 12.50 USD

0.10 (0.81%)

MORE ON AGAM

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AGA Medical Holdings, Inc. (NasdaqNM:AGAM) Delayed quote data

Last Trade:	12.50 USD
Trade Time:	1:59PM EST
Change:	0.10 (0.81%)
Prev Close:	12.40
Open:	12.43
Bid:	12.49 x 200
Ask:	12.50 x 100
1y Target Est:	N/A

Day's Range:	12.22 - 12.54
52wk Range:	11.91 - 14.85
Volume:	103,569
Avg Vol (3m):	513,076
Market Cap:	626.17M
P/E (ttm):	N/A
EPS (ttm):	-0.77
Div & Yield:	N/A (N/A%)

1d 5d 3m

Free Annual Reports

Add AGAM to Portfolio

Download Data

HEADLINES

•	AGA Medical Adds Jack P. Helms to Board of Directors
	Business Wire (Wed, Nov 18)

•	AGA MEDICAL HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	Citi's Primerica IPO May Signal Strategy Shift
	at TheStreet.com (Mon, Nov 9)

•	Citi's Primerica IPO Points to Strategy Shift
	at TheStreet.com (Mon, Nov 9)

•	Most Successful IPO Is Dole, Says Poll
	at TheStreet.com (Sat, Nov 7)

•	AGA MEDICAL HOLDINGS, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements
	EDGAR Online (Wed, Nov 4)

•	AGA Medical Receives Product Approvals in China
	Business Wire (Wed, Nov 4)

•	AGA Medical Holdings, Inc. Earnings Call scheduled for 5:00 pm ET today
	CCBN (Tue, Nov 3)

•	AGA MEDICAL HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
	EDGAR Online (Tue, Nov 3)

•	AGA Medical Reports 2009 Third Quarter Financial Results
	Business Wire (Tue, Nov 3)

More Headlines for AGAM...

BUSINESS SUMMARY

AGA Medical Holdings, Inc., through its subsidiary, manufactures and markets medical devices and accessories for the treatment of cardiovascular defects and peripheral vascular diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•